Abstract:Background PD-1/PD-L1 blockades have shown promising antitumor activity in clinical trials of advanced nasopharyngeal carcinoma (NPC). Being the most wildly used molecular imaging in clinic, 18F-FDG PET/CT provides multiple information of tumor biology. In this study, we investigated the association of PD-L1 expression with 18F-FDG uptake and clinical features in patients with NPC. Methods 84 patients were initially histopathologically diagnosed with NPC between December 2016 and March 2019. All tissue specimens and PET/CT images were collected before any treatment. The PD-L1 antibody we used in this investigation was SP263 (Ventana, USA). High PD-L1 expression in tumor cells (TC) or tumor-infiltrating immune cells (TIIC) was defined as≥50% of corresponding cells with membranous staining. Results The values of tumor SUVmax and TLG in patients with positive TC PD-L1 expression were significantly higher than those of negative TC PD-L1 expression (SUVmax: 10.3±4.1 vs. 6.9±3.2; P<0.001; TLG: 77.7±64.5 vs. 35.0±20.5; P<0.001), while the SUVmax values and TLG in patients with positive TIIC PD-L1 expression is lower than those of negative TIIC PD-L1 expression (SUVmax: 7.0±3.4 vs. 9.7±4.1; P=0.011; TLG: 29.1±14.4 vs. 71.3±61.2; P=0.001). Univariate analysis showed that the expression of PD-L1 in TC was associated with tumor T stage (P=0.044) but not with serum Epstein-Barr virus (EBV) load (P=0.816). On the other hand, the expression of PD-L1 in TIIC was related to both T stage (P=0.028) and serum EBV load (P=0.003). In multivariate logistic regression analysis, PD-L1 expression in TC was positively associated with tumor SUVmax (P=0.003) and TLG (P=0.001), while PD-L1 expression in TIIC was negatively associated with SUVmax (P=0.038) and serum EBV load (P=0.025). Through the ROC curve, the SUVmax cut-off value of 6.7 and the TLG cut-off value of 41.3 can be used to predict the PD-L1 status in TC with an accuracy of 78.6% and 71.4%, while the SUVmax cut-off value of 7.2 can be used to predict the PD-L1 status in TIIC with an accuracy of 72.6%. Conclusions 18F-FDG uptake with NPC lesions were positively correlated with PD-L1 expression in TC and negatively correlated with PD-L1 expression in TIIC. 18F-FDG PET / CT imaging may be useful for predicting the PD-L1 status in patients with NPC. Legal entity responsible for the study The authors. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest.

Reflecting on the utility of standardized uptake values on 18F-FDG PET in nasopharyngeal carcinoma

Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma

18F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor

Prognostic Value of Pretreatment 18F-FDG PET-CT for Nasopharyngeal Carcinoma Patients.

Adding Maximum Standard Uptake Value of Primary Lesion and Lymph Nodes in 18F-Fluorodeoxyglucose PET Helps Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.

PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma

Prognostic value of lymph node-to-primary tumor ratio of PET standardized uptake value for nasopharyngeal carcinoma: a recursive partitioning risk stratification analysis

Prognostic Value of Pre-Treatment FDG PET/CT SUVmax for Metastatic Lesions in De Novo Metastatic Nasopharyngeal Carcinoma Following Chemotherapy and Locoregional Radiotherapy

Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study

Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients

Prognostic Relevance of 18F-FDG-PET/CT-Guided Target Volume Delineation in Loco-Regionally Advanced Nasopharyngeal Carcinomas: A Comparative Study

The Utility of 18 F-FDG-PET–CT Metabolic Parameters in Evaluating the Primary Tumor Aggressiveness and Lymph Node Metastasis of Nasopharyngeal Carcinoma

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein–barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma

Parametric Contrast-Enhanced Ultrasound As an Early Predictor of Radiation-Based Therapeutic Response for Lymph Node Metastases of Nasopharyngeal Carcinoma.

18F-FLT and 18F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results.

[Pretreatment evaluation of 18F-FDG PET-CT in extranodal NK/T-cell lymphoma]

Establishment and Validation of a Nomogram with Intratumoral Heterogeneity Derived from 18F-FDG PET/CT for Predicting Individual Conditional Risk of 5-Year Recurrence Before Initial Treatment of Nasopharyngeal Carcinoma.

Predictive Value Of Suvmax Measured By F-18-Fdg Pet/Ct In Patients With Early Stage Non-Small Cell Lung Cancer

Role of 18F-FDG PET/CT SUVmax in Predicting Recurrence and Prognosis for Non-Small Cell Lung Cancer Patients

[18F]-FDG PET/CT in predicting PD-L1 status in nasopharyngeal carcinoma